about
Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional ActivityGeneration of a haptoglobin-hemoglobin complex-specific Fab antibody blocking the binding of the complex to CD163.Identification of the haemoglobin scavenger receptor.CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma.Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liverTetranectin, a trimeric plasminogen-binding C-type lectin.Anti-inflammatory liposomes have no impact on liver regeneration in ratsAnti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats.Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.Haptoglobin.Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties.The Staphylococcus aureus Protein IsdH Inhibits Host Hemoglobin Scavenging to Promote Heme Acquisition by the Pathogen.Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL.Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region.A pivotal role of the human kidney in catabolism of HDL protein components apolipoprotein A-I and A-IV but not of A-II.Targeting dexamethasone to macrophages in a porcine endotoxemic model.Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.Immunomodulating peptides derived from different human endogenous retroviruses (HERVs) show dissimilar impact on pathogenesis of a multiple sclerosis animal disease model.CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and MucosaNovel Monoclonal Antibodies Against Native Human Collectin L1, Using the Heteromeric Complex CL-LK as ImmunogenEfficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasmaTargeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriolCrystallization and molecular-replacement solution of a truncated form of human recombinant tetranectinTetranectin-binding site on plasminogen kringle 4 involves the lysine-binding pocket and at least one additional amino acid residueThe class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophagesAPOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinSTAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomesSpecific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regressionUsing the hemoglobin-binding Staphylococcus aureus protein IsdH to enable plasma analysis of hemolyzed blood samplesContact activation-induced complex formation between complement factor H and coagulation factor XIIa
P50
Q24804463-2F0EE714-E4A2-4265-9467-A374246AC023Q31155475-8CA6DCF2-0ED0-409A-ABE1-7A12A38E3744Q33934404-52994BB8-0911-4332-A845-683A977026DFQ34114924-C8DA7573-31DF-43F9-B9F6-D5DDABFD0036Q36142511-1C09C6A4-345D-4F78-9418-682173124B3EQ36146299-C29D7B15-58E5-44FA-ABBB-F440FA3CD354Q36280485-9FC88504-2088-4126-8523-E2EDEA6A21FBQ36387936-7DCBC8A4-CB62-4F88-BC8A-6801751CFD52Q37014721-D7660DB8-C13D-4A82-B990-F0C27E91E003Q38537751-5D3B2346-1BA7-4DF0-9E6F-0FDAA8CDA481Q38819335-B1233E74-F12A-4F14-A49A-C226E0E6793BQ40010946-1B3004FA-07E3-4C11-890C-AB1DC952717DQ40524327-635C779D-CF88-417B-BEAE-3172E2B013E5Q42284206-4B2773DA-8620-46EA-A931-192D3CF78489Q44279948-6261367C-08CB-4B42-8931-674F6EC1B57BQ45078050-23BDDA7D-A0B4-4836-BB13-83E5214AB93CQ46694128-1929F4C1-E5C7-498F-8E9C-31A8174E1FECQ47824054-2419AC3C-BE16-47D5-BEA8-3A39DB31BC73Q51768718-5C1A6CC6-504A-4935-8BCE-475DE5E254E3Q54753464-5FB1DA22-C45F-4E3C-AE68-310544B0AB28Q58455938-17B13008-E283-476D-BE89-01BED0101324Q58568934-826B9E97-56ED-4F65-A447-D8ACF4CD255FQ60405455-B3EB9BC1-AC39-4F70-B256-BAE3480F7F21Q60405643-51C8C093-B5C8-42DE-A8A1-245C858AC35BQ64097117-90B0038D-76D2-461B-8E67-9770C1AFD0CAQ73689934-01E71166-61E9-4474-B5B7-5BEAAA9858FAQ73905630-74C0A46B-1A49-46F8-847E-B290017EC0A8Q89777848-B316B9BE-FD4A-4A34-A2D2-5C633F8DF77DQ90429692-9045F130-4493-488C-94DF-21AECE06E31BQ91021394-80B4D3CC-B3BE-4F23-9513-9B67D98B5514Q92376163-BD814CB3-2497-4DF5-9D4F-7172B9F4EC60Q92955876-2ED3F535-1C22-4A82-B28F-A1622ADDC857Q92958083-458528C7-9873-4564-807F-8F7360CAD948
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7119-2108
@en
name
Jonas Heilskov Graversen
@ast
Jonas Heilskov Graversen
@en
Jonas Heilskov Graversen
@es
Jonas Heilskov Graversen
@nl
type
label
Jonas Heilskov Graversen
@ast
Jonas Heilskov Graversen
@en
Jonas Heilskov Graversen
@es
Jonas Heilskov Graversen
@nl
prefLabel
Jonas Heilskov Graversen
@ast
Jonas Heilskov Graversen
@en
Jonas Heilskov Graversen
@es
Jonas Heilskov Graversen
@nl
P108
P106
P1153
6602864308
P21
P31
P496
0000-0001-7119-2108